Clinical Trial Update: High Dose Oral Steroids in Sudden Sensorineural Hearing Loss [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating high-dose oral steroids for sudden Sensorineural Hearing Loss has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sudden Sensorineural Hearing Loss

Snippet

Sponsor: University of Colorado, Denver | Conditions: Sudden Sensorineural Hearing Loss (SSNHL) | Phase 2 | Status: WITHDRAWN